Acadia Pharmaceuticals | ACAD - ДОЛГ

Биржевая цена
21.85
Изменение за день
-0.60 -2.67%
Ежемесячно
-1.58%
Ежегодный
46.55%
Q2 прогноз
21.49




ДОЛГ Изменить Дата
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
ALKERMES USD 71.6M 1.08M 2025-09
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Biogen USD 6.56B 275.1M 2026-03
BioMarin Pharmaceutical USD 604.24M 375K 2025-09
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Cara Therapeutics USD 0 0 2025-03
Corcept Therapeutics USD 6.11M 251K 2025-12
Cytokinetics USD 1.2B 338.79M 2025-09
Eisai JPY 236.67B 49.14B 2025-09
Eli Lilly USD 42.5B 3.6M 2025-12
Incyte USD 40.41M 855K 2025-12
J&J USD 47.93B 2.14B 2025-12
Moderna USD 1.31B 571M 2025-12
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Pfizer USD 60.85B 78M 2025-09
Prothena USD 9.08M 699K 2025-09
PTC Therapeutics USD 2.71B 2.42B 2025-12
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Ultragenyx Pharmaceutical USD 33.83M 2.46M 2025-09
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09